Send the following on WhatsApp
Continue to Chat2seventy bio stock drops 24% as competition catches up with BMS-partnered multiple myeloma drug https://invesbrain.com/2seventy-bio-stock-drops-24-as-competition-catches-up-with-bms-partnered-multiple-myeloma-drug/